Zubi Sadiq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zubi Sadiq has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sana Jahanshahi-Anbuhi
Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science, Concordia University, Montreal, Quebec, Canada
4 shared publications Maryam Mansouri
Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science, Concordia University, Montreal, Quebec, Canada
2 shared publicationsSeyed Hamid Safiabadi Tali
Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science, Concordia University, Montreal, Quebec, Canada
2 shared publications- Seyed Hamid Safiabadi Tali
Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science, Concordia University, Montréal, QC H4B 1R6, Canada
2 shared publications - Chinonso Henry Ezeoke
Department of Chemical and Materials Engineering, Gina Cody School of Engineering and Computer Science, Concordia University, Montréal, QC H4B 1R6, Canada
1 shared publication - Hasti Hajimiri
Department of Chemical and Materials Engineering, Gina Cody School of Engineering, Concordia University, Montreal, QC H3G 2W1, Canada
1 shared publication
Latest Publications
- 9 November 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (22) , 6745-6755
Effervescent sensing tablets for clean handling and shake-free, rapid copper detection in water
An auto-mixing effervescent tablet incorporating BCA reagents was developed for smartphone-assisted colorimetric quantification of Cu 2+ in water, achieving an LOD of 0.03 mg L −1 .
- 9 November 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (22) , 6745-6755
Effervescent sensing tablets for clean handling and shake-free, rapid copper detection in water
An auto-mixing effervescent tablet incorporating BCA reagents was developed for smartphone-assisted colorimetric quantification of Cu 2+ in water, achieving an LOD of 0.03 mg L −1 .
- Open Access
- 8 October 2025
- Published by MDPI AG in Chemosensors
- Vol. 13 (10) , 365
Reverse Titration Using Tablets for Accurate Water Hardness Measurement with Improved Resistance to Interference
We report a novel tablet-based reverse titration system for rapid, point-of-use measurement of water hardness, overcoming key limitations of conventional EDTA titration. Reagents are encapsulated in pullulan matrix giving two separate tablets. The first tablet contains the Eriochrome black T (EBT) and N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer, while the second encapsulates ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate. The system employs a trimodal detection strategy: qualitative screening via immediate color change with the EBT tablet, semi-quantitative estimation through combined tablet dissolution and adjusting the sample volume to a reference level, and quantitative determination using reverse titration, where water is gradually added until the red wine endpoint appears. This approach enhances interference tolerance from competing metal ions and improves accuracy over traditional methods. Testing with real water samples showed excellent agreement with standard titration. The tablets remain stable for over seven months, and the system eliminates the need for skilled personnel, laboratory equipment, or bulky instrumentation. This low-cost, user-friendly, and interference-tolerant platform enables rapid and accurate water hardness assessment at the point of use.
- 8 October 2025
- Published by MDPI AG in Chemosensors
- Vol. 13 (10) , 365
Open AccessReverse Titration Using Tablets for Accurate Water Hardness Measurement with Improved Resistance to Interference
We report a novel tablet-based reverse titration system for rapid, point-of-use measurement of water hardness, overcoming key limitations of conventional EDTA titration. Reagents are encapsulated in pullulan matrix giving two separate tablets. The first tablet contains the Eriochrome black T (EBT) and N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer, while the second encapsulates ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate. The system employs a trimodal detection strategy: qualitative screening via immediate color change with the EBT tablet, semi-quantitative estimation through combined tablet dissolution and adjusting the sample volume to a reference level, and quantitative determination using reverse titration, where water is gradually added until the red wine endpoint appears. This approach enhances interference tolerance from competing metal ions and improves accuracy over traditional methods. Testing with real water samples showed excellent agreement with standard titration. The tablets remain stable for over seven months, and the system eliminates the need for skilled personnel, laboratory equipment, or bulky instrumentation. This low-cost, user-friendly, and interference-tolerant platform enables rapid and accurate water hardness assessment at the point of use.
- Open Access
- 20 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 7 (10) , 2967-2978
A dual-functional nanogold tablet as a plasmonic and nanozyme sensor for point-of-care applications
Point-of-care (POC) devices provide on-site disease diagnosis, particularly in resource-limited settings. Despite considerable progress in POC testing, the availability of commercial devices remains limited, primarily due to challenges in detection sensitivity and portability. Furthermore, advancements in existing POC devices are essential to better meet the needs of end-users. Herein, we present a colorimetric dual-functional tablet sensor using dextran-gold nanoparticles (dAuNPs) to detect and quantify uric acid and glucose levels in urine. Our tablet sensor combines the plasmonic and nanozyme properties of dAuNPs, resulting in highly sensitive detection of both biomarkers. Interestingly, we fabricated the nanogold tablet directly from the dAuNP solution without the addition of any external stabilizer or tablet-forming reagent, thus naming it a direct tablet. An enzyme-free approach was employed for uric acid detection, providing a wide detection range of 0.00187–7.8 mM and a low detection limit of 0.0037 mM, attributed to the hydrogen bonding between dextran and uric acid. On the other hand, the unique nanozyme properties of dAuNPs exhibited exclusive POx-mimetic activity for glucose detection (Km = 0.106 mM and Vmax = 369.72 mM min−1), with a lower detection limit of 0.625 mM. Our dual-functional tablet offers exceptional substrate selectivity for the colorimetric–chromogenic assay of both uric acid and glucose. This dual-functionality not only provides a highly sensitive, selective, and cost-effective detection strategy for resource-limited settings but also introduces a new avenue for designing customizable plasmonic-nanozyme nanogold tablet sensors as a powerful tool for rapid diagnosis.
- 20 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 7 (10) , 2967-2978
Open AccessA dual-functional nanogold tablet as a plasmonic and nanozyme sensor for point-of-care applications
Point-of-care (POC) devices provide on-site disease diagnosis, particularly in resource-limited settings. Despite considerable progress in POC testing, the availability of commercial devices remains limited, primarily due to challenges in detection sensitivity and portability. Furthermore, advancements in existing POC devices are essential to better meet the needs of end-users. Herein, we present a colorimetric dual-functional tablet sensor using dextran-gold nanoparticles (dAuNPs) to detect and quantify uric acid and glucose levels in urine. Our tablet sensor combines the plasmonic and nanozyme properties of dAuNPs, resulting in highly sensitive detection of both biomarkers. Interestingly, we fabricated the nanogold tablet directly from the dAuNP solution without the addition of any external stabilizer or tablet-forming reagent, thus naming it a direct tablet. An enzyme-free approach was employed for uric acid detection, providing a wide detection range of 0.00187–7.8 mM and a low detection limit of 0.0037 mM, attributed to the hydrogen bonding between dextran and uric acid. On the other hand, the unique nanozyme properties of dAuNPs exhibited exclusive POx-mimetic activity for glucose detection (Km = 0.106 mM and Vmax = 369.72 mM min−1), with a lower detection limit of 0.625 mM. Our dual-functional tablet offers exceptional substrate selectivity for the colorimetric–chromogenic assay of both uric acid and glucose. This dual-functionality not only provides a highly sensitive, selective, and cost-effective detection strategy for resource-limited settings but also introduces a new avenue for designing customizable plasmonic-nanozyme nanogold tablet sensors as a powerful tool for rapid diagnosis.
- Open Access
- 19 September 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (9) , 893
Tablet-Based Sensor: A Stable and User-Friendly Tool for Point-of-Care Detection of Glucose in Urine
The colorimetric detection of glucose in urine through enzymatic reactions offers a low-cost and non-invasive method to aid in diabetes management. Nonetheless, the vulnerability of enzymes to environmental conditions, particularly elevated temperatures, and their activity loss pose significant challenges for transportation and storage. In this work, we developed a stable and portable tablet sensor as a user-friendly platform for glucose monitoring. This innovative device encapsulates glucose oxidase and horseradish peroxidase enzymes with dextran, transforming them into solid tablets and ensuring enhanced stability and practicality. The enzymatic tablet-based sensor detected glucose in urine samples within 5 min, using 3,3′,5,5′-tetramethylbenzidine (TMB) as the indicator. The tablet sensor exhibited responsive performance within the clinically relevant range of 0–6 mM glucose, with a limit of detection of 0.013 mM. Furthermore, the tablets detected glucose in spiked real human urine samples, without pre-processing, with high precision. Additionally, with regard to thermal stability, the enzyme tablets better maintained their activity at an elevated temperature as high as 60 °C compared to the solution-phase enzymes, demonstrating the enhanced stability of the enzymes under harsh conditions. The availability of these stable and portable tablet sensors will greatly ease the transportation and application of glucose sensors, enhancing the accessibility of glucose monitoring, particularly in resource-limited settings.
- 19 September 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (9) , 893
Open AccessTablet-Based Sensor: A Stable and User-Friendly Tool for Point-of-Care Detection of Glucose in Urine
The colorimetric detection of glucose in urine through enzymatic reactions offers a low-cost and non-invasive method to aid in diabetes management. Nonetheless, the vulnerability of enzymes to environmental conditions, particularly elevated temperatures, and their activity loss pose significant challenges for transportation and storage. In this work, we developed a stable and portable tablet sensor as a user-friendly platform for glucose monitoring. This innovative device encapsulates glucose oxidase and horseradish peroxidase enzymes with dextran, transforming them into solid tablets and ensuring enhanced stability and practicality. The enzymatic tablet-based sensor detected glucose in urine samples within 5 min, using 3,3′,5,5′-tetramethylbenzidine (TMB) as the indicator. The tablet sensor exhibited responsive performance within the clinically relevant range of 0–6 mM glucose, with a limit of detection of 0.013 mM. Furthermore, the tablets detected glucose in spiked real human urine samples, without pre-processing, with high precision. Additionally, with regard to thermal stability, the enzyme tablets better maintained their activity at an elevated temperature as high as 60 °C compared to the solution-phase enzymes, demonstrating the enhanced stability of the enzymes under harsh conditions. The availability of these stable and portable tablet sensors will greatly ease the transportation and application of glucose sensors, enhancing the accessibility of glucose monitoring, particularly in resource-limited settings.